Epalrestat Powder Cas No.82159-09-9
Product source: Synthetic products
Content specification: ≥ 98%
CAS NO:82159-09-9
The chemical formula is: C15H13NO3S2
Molecular weight: 319.4
Detection method: HPLC
Active ingredient: Epalrestat
Product Description: Yellow to orange powder or deep red needle shaped crystals
Product usage: Medical and scientific research
Product packaging: 1kg/bag; 25kg/barrel
Product storage: Keep in a ventilated, low temperature, dry environment, away from light, recommended temperature is -20 ℃
Shelf life: 24 months
Products Description
Xi'an Tihealth High Purity Epalrestat
Xi'an Tihealth provides pharmaceutical grade high-purity Epastatin raw materials. The main component content of the product is stable at ≥ 98% (detected by HPLC) and meets the standard characteristics. As a key aldose reductase inhibitor, this product is dedicated to the research, development and production of drugs for the treatment of diabetes neuropathy. We provide flexible packaging (from research and development samples to production batches), and store and transport under strict temperature control (recommended -20 ℃) and dark and dry conditions to ensure product stability and provide reliable guarantee for your pharmaceutical projects.
Products Function
Ipastatin inhibits the activity of aldose reductase (AR), blocks the abnormal activation of the sorbitol pathway induced by hyperglycemia, reduces the accumulation of sorbitol and fructose in nerve tissue, and thus alleviates nerve fiber degeneration and demyelination. Specifically manifested in:
Symptom relief, nerve repair, blood flow restoration
1. Multidimensional improvement of diabetes neuropathy
2. Renal protection and metabolic regulation
3. Anti inflammatory and immune regulation
Reduce glycation end products (AGEs) and antioxidant stress
Ipastatin can inhibit the expression of pro-inflammatory factors such as interleukin-1 β (IL-1 β) and tumor necrosis factor - α (TNF - α), alleviate neurointimal inflammation, regulate immune cell activity, and reduce the risk of neurological recurrence.
Products Aplication
1. For treatment of complications of diabetes:
• Diabetes peripheral neuropathy (DPN): improve limb numbness, pain and paresthesia.
• Diabetes retinopathy: delay the decline of vision caused by microvascular damage.
2. Drug development: raw materials used for DPN treatment drugs (such as tablets, capsules).
Mechanism of Action
1,Target inhibition:
Selectively binds to the active site of aldose reductase, inhibiting its ability to catalyze the conversion of glucose to sorbitol.
2,Pathological correction:
Reduces intracellular sorbitol concentration, restores osmotic pressure balance, alleviates edema and oxidative stress damage in nerve cells, and repairs nerve conduction function.
Hot Tags: epalrestat powder cas no.82159-09-9, China epalrestat powder cas no.82159-09-9 manufacturers, suppliers, factory
You Might Also Like
Send Inquiry











